Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.08 SEK | +0.98% | +19.84% | -0.65% |
22/05 | Enorama Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
28/02 | Intervacc's Acting CEO Assumes Role Permanently | MT |
Business Summary
Number of employees: 5
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Nicotine Gum
100.0
%
| 7 | 100.0 % | 1 | 100.0 % | -80.17% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 7 | 100.0 % | 1 | 100.0 % | -80.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Annette Agerskov
CEO | Chief Executive Officer | 64 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 61 | 01/16/01 | |
- | - | ||
Daniel Schroeder
BRD | Director/Board Member | - | - |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 46,150,678 | 16,243,428 ( 35.20 %) | 0 | 35.20 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-0.65% | 11.87M | |
+20.54% | 43.29B | |
+27.64% | 22.38B | |
+19.88% | 15.51B | |
+18.92% | 14.52B | |
+54.85% | 12.93B | |
-0.05% | 6.79B | |
-11.39% | 6.56B | |
+17.73% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- ERMA Stock
- Company Enorama Pharma AB